cornuside has been researched along with Cognitive Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; He, XL; Li, M; Lian, WW; Liu, LQ; Pan, CH; Wang, YM; Wang, ZX; Xu, JK; Zhang, WK | 1 |
| Bai, X; Che, R; He, J; He, X; Lian, W; Tu, S; Xu, J; Yu, L; Zhang, W | 1 |
2 other study(ies) available for cornuside and Cognitive Dysfunction
| Article | Year |
|---|---|
Cornuside ameliorates cognitive impairments in scopolamine induced AD mice: Involvement of neurotransmitter and oxidative stress.
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Amnesia; Animals; Butyrylcholinesterase; Choline O-Acetyltransferase; Cognitive Dysfunction; Glucosides; Hippocampus; Maze Learning; Mice; Mice, Inbred ICR; Monoamine Oxidase; Neurotransmitter Agents; Oxidative Stress; Pyrans; Scopolamine; Superoxide Dismutase | 2022 |
Cornuside, by regulating the AGEs-RAGE-IκBα-ERK1/2 signaling pathway, ameliorates cognitive impairment associated with brain aging.
Topics: Aging; Alzheimer Disease; Animals; Brain; Cognitive Dysfunction; Galactose; Glycation End Products, Advanced; MAP Kinase Signaling System; Mice; NF-KappaB Inhibitor alpha; Oxidative Stress; Signal Transduction | 2023 |